Vault-13

FRAZIER MANAGEMENT LLC

SEATTLE, WA · CIK 1032165 · 13F filing filed 2021-08-11

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

As an employer

US visa salary filings

Job titleFilingsMedianRange
Associate, Investment AnalystSeattle, WA 1 $125,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.

$1.1bn reported value -13.0% vs Q1 2021
34positions
78.0%in top 10
2 new 1 added 8 reduced 3 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,434,232 $230.2m21.23% 21.23% ReducedShares held: Q3 2020 10.5m, Q4 2020 10.5m, Q1 2021 10.5m, Q2 2021 8.4m -2.1m -2,108,558 -20.0%
2 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 5,827,415 $197.3m18.19% 18.19% UnchangedShares held: Q3 2020 5.8m, Q4 2020 5.8m, Q1 2021 5.8m, Q2 2021 5.8m
3 PASSAGE BIO INC COM COM 5,009,219 $66.3m6.12% 6.12% UnchangedShares held: Q3 2020 5.0m, Q4 2020 5.0m, Q1 2021 5.0m, Q2 2021 5.0m
4 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,566,912 $61.7m5.69% 5.69% UnchangedShares held: Q3 2020 3.6m, Q4 2020 3.6m, Q1 2021 3.6m, Q2 2021 3.6m
5 TRANSLATE BIO INC COM COM 2,082,789 $57.4m5.29% 5.29% ReducedShares held: Q3 2020 2.2m, Q4 2020 2.2m, Q1 2021 2.2m, Q2 2021 2.1m -100.0k -100,000 -4.6%
6 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 2,137,999 $55.6m5.13% 5.13% AddedShares held: Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 2.1m +825.0k +825,000 62.8%
7 KRYSTAL BIOTECH INC COM KRYS KRYS 787,876 $53.6m4.94% 4.94% ReducedShares held: Q3 2020 895.0k, Q4 2020 895.0k, Q1 2021 895.0k, Q2 2021 787.9k -107.1k -107,124 -12.0%
8 VAXCYTE INC COM PCVX PCVX 2,309,554 $52.0m4.79% 4.79% UnchangedShares held: Q3 2020 2.3m, Q4 2020 2.3m, Q1 2021 2.3m, Q2 2021 2.3m
9 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,417,157 $41.1m3.79% 3.79% ReducedShares held: Q3 2020 0, Q4 2020 1.9m, Q1 2021 1.9m, Q2 2021 1.4m -500.0k -500,000 -26.1%
10 TRILLIUM THERAPEUTICS INC COM NEW TR TR 3,123,107 $30.3m2.79% 2.79% UnchangedShares held: Q3 2020 2.8m, Q4 2020 3.1m, Q1 2021 3.1m, Q2 2021 3.1m
11 ANAPTYSBIO INC COM ANAB ANAB 899,700 $23.3m2.15% 2.15% UnchangedShares held: Q3 2020 2.3m, Q4 2020 899.7k, Q1 2021 899.7k, Q2 2021 899.7k
12 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,571,450 $23.1m2.13% 2.13% UnchangedShares held: Q3 2020 2.6m, Q4 2020 2.6m, Q1 2021 2.6m, Q2 2021 2.6m
13 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,188,135 $20.4m1.88% 1.88% ReducedShares held: Q3 2020 1.3m, Q4 2020 1.4m, Q1 2021 1.4m, Q2 2021 1.2m -246.9k -246,910 -17.2%
14 SUTRO BIOPHARMA INC COM COM 1,001,421 $18.6m1.72% 1.72% UnchangedShares held: Q3 2020 0, Q4 2020 1.0m, Q1 2021 1.0m, Q2 2021 1.0m
15 IVERIC BIO INC COM OPHT OPHT 2,544,500 $16.1m1.48% 1.48% UnchangedShares held: Q3 2020 2.4m, Q4 2020 2.5m, Q1 2021 2.5m, Q2 2021 2.5m
16 CHINOOK THERAPEUTICS INC COM ADRO ADRO 1,100,000 $15.5m1.43% 1.43% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 1.1m
17 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 2,283,966 $15.2m1.40% 1.40% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 2.3m
18 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 UNIT 12/09/2025 1,501,000 $15.1m1.39% 1.39% UnchangedShares held: Q3 2020 0, Q4 2020 1.5m, Q1 2021 1.5m, Q2 2021 1.5m
19 REGENXBIO INC COM RGNX RGNX 351,954 $13.7m1.26% 1.26% UnchangedShares held: Q3 2020 174.2k, Q4 2020 342.0k, Q1 2021 352.0k, Q2 2021 352.0k
20 MOLECULAR TEMPLATES INC COM COM 1,374,047 $10.7m0.99% 0.99% UnchangedShares held: Q3 2020 0, Q4 2020 841.9k, Q1 2021 1.4m, Q2 2021 1.4m
21 GRITSTONE BIO INC COM GRTS GRTS 1,030,878 $9.4m0.87% 0.87% UnchangedShares held: Q3 2020 2.1m, Q4 2020 2.1m, Q1 2021 1.0m, Q2 2021 1.0m
22 ESSA PHARMA INC COM NEW EPI EPI 316,616 $9.0m0.83% 0.83% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 316.6k, Q2 2021 316.6k
23 ACLARIS THERAPEUTICS INC COM ACRS ACRS 370,733 $6.5m0.60% 0.60% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 696.0k, Q2 2021 370.7k -325.3k -325,267 -46.7%
24 EPIZYME INC COM EPZM EPZM 739,369 $6.1m0.57% 0.57% UnchangedShares held: Q3 2020 0, Q4 2020 731.4k, Q1 2021 739.4k, Q2 2021 739.4k
25 APTINYX INC COM COM 1,883,244 $5.3m0.49% 0.49% ReducedShares held: Q3 2020 3.2m, Q4 2020 3.2m, Q1 2021 3.2m, Q2 2021 1.9m -1.3m -1,306,835 -41.0%
26 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 156,000 $4.5m0.42% 0.42% UnchangedShares held: Q3 2020 0, Q4 2020 153.5k, Q1 2021 156.0k, Q2 2021 156.0k
27 FREELINE THERAPEUTICS HLDGS SPONSORED ADS SPONSORED ADS 550,000 $4.5m0.41% 0.41% UnchangedShares held: Q3 2020 550.0k, Q4 2020 550.0k, Q1 2021 550.0k, Q2 2021 550.0k
28 ALLENA PHARMACEUTICALS COM ALNA ALNA 3,330,373 $4.3m0.40% 0.40% UnchangedShares held: Q3 2020 3.3m, Q4 2020 3.3m, Q1 2021 3.3m, Q2 2021 3.3m
29 BELLUS HEALTH INC NEW COM NEW BLU BLU 1,296,743 $4.0m0.37% 0.37% UnchangedShares held: Q3 2020 1.3m, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 1.3m
30 SIERRA ONCOLOGY INC COM NEW COM NEW 202,803 $3.9m0.36% 0.36% UnchangedShares held: Q3 2020 202.8k, Q4 2020 202.8k, Q1 2021 202.8k, Q2 2021 202.8k
31 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 578,104 $3.9m0.36% 0.36% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 578.1k, Q2 2021 578.1k
32 IMMUNOVANT INC COM IMVT IMVT 254,000 $2.7m0.25% 0.25% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 508.0k, Q2 2021 254.0k -254.0k -254,000 -50.0%
33 GALERA THERAPEUTICS INC COM COM 241,000 $2.4m0.22% 0.22% UnchangedShares held: Q3 2020 0, Q4 2020 241.0k, Q1 2021 241.0k, Q2 2021 241.0k
34 NABRIVA THERAPEUTICS PLC SHS SHS 425,650 $575.0k0.05% 0.05% UnchangedShares held: Q3 2020 0, Q4 2020 425.6k, Q1 2021 425.6k, Q2 2021 425.6k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
ADVERUM BIOTECHNOLOGIES INC 1,437,028 $14.2m1.4m shares
CARDIFF ONCOLOGY INC CRDF CRDF 293,500 $2.7m293.5k shares
ITERUM THERAPEUTICS PLC ITRMF ITRMF 1,538,316 $2.2m1.5m shares